De novo cardiomyocytes from within the activated adult heart after injury.
A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable source of stem/progenitor cells that could contribute new muscle after ischaemic heart disease and acute myocardial infarction. A therapeutic ideal--relative to cell transplantation--would be to stimul...
Main Authors: | Smart, N, Bollini, S, Dubé, K, Vieira, J, Zhou, B, Davidson, S, Yellon, D, Riegler, J, Price, A, Lythgoe, M, Pu, W, Riley, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart.
by: Smart, N, et al.
Published: (2012) -
Resident cardiac progenitor cells: at the heart of regeneration.
by: Bollini, S, et al.
Published: (2011) -
Re-activated adult epicardial progenitor cells are a heterogeneous population molecularly distinct from their embryonic counterparts.
by: Bollini, S, et al.
Published: (2014) -
An essential role for thymosin beta 4 in regulating vascular smooth muscle cell development and adult vessel stability
by: Smart, N, et al.
Published: (2012) -
Thymosin β4 protein therapy for cardiac repair.
by: Dubé, K, et al.
Published: (2012)